Baxter Debt Issuance/Retirement Net - Total 2010-2025 | BAX
Baxter annual/quarterly debt issuance/retirement net - total history and growth rate from 2010 to 2025. Debt issuance/retirement net - total can be defined as the total amount of short term and long term borrowings repaid and issued.
- Baxter debt issuance/retirement net - total for the quarter ending March 31, 2025 was $-3.125B, a 20733.33% increase year-over-year.
- Baxter debt issuance/retirement net - total for the twelve months ending March 31, 2025 was $-5.307B, a 61.7% increase year-over-year.
- Baxter annual debt issuance/retirement net - total for 2024 was $-0.531B, a 81.91% decline from 2023.
- Baxter annual debt issuance/retirement net - total for 2023 was $-2.935B, a 226.47% increase from 2022.
- Baxter annual debt issuance/retirement net - total for 2022 was $-0.899B, a 109.64% decline from 2021.
| Baxter Annual Debt Issuance/Retirement Net - Total (Millions of US $) |
|
|---|---|
| 2024 | $-531 |
| 2023 | $-2,935 |
| 2022 | $-899 |
| 2021 | $9,326 |
| 2020 | $478 |
| 2019 | $1,883 |
| 2018 | $N/A |
| 2017 | $665 |
| 2016 | $-40 |
| 2015 | $2,507 |
| 2014 | $-113 |
| 2013 | $3,096 |
| 2012 | $765 |
| 2011 | $733 |
| 2010 | $91 |
| 2009 | $473 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MED PRODUCTS | $14.559B | $10.636B |
| Baxter International Inc. is a global medical technology company. The company consists of renal and hospital products, providing items such as kidney-dialysis equipment, infusion pumps, and intravenous (IV) solutions. Baxter has been reporting through six revenue segments. Renal Care, Medication Delivery, Pharmaceuticals, Clinical Nutrition, Advanced Surgery, Acute Therapies and Other. Baxter's Renal segment primarily consists of Peritoneal Dialysis (PD) and Hemodialysis (HD) therapies. The portfolio addresses the needs of patients with kidney failure or kidney disease, and their healthcare providers, with a comprehensive range of therapeutic options across home, in-center, and hospital settings for better individualized care. | |||